These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17230473)

  • 1. Vitamin D and Parkinson's disease--a hypothesis.
    Newmark HL; Newmark J
    Mov Disord; 2007 Mar; 22(4):461-8. PubMed ID: 17230473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrimental deletions: mitochondria, aging and Parkinson's disease.
    Biskup S; Moore DJ
    Bioessays; 2006 Oct; 28(10):963-7. PubMed ID: 16998822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment of Parkinson's disease].
    Maciaczyk J; Swietaszczyk C; Kasprzak HA
    Przegl Lek; 2004; 61(12):1383-8. PubMed ID: 15850334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D: preventive and therapeutic potential in Parkinson's disease.
    Liu Y; Li YW; Tang YL; Liu X; Jiang JH; Li QG; Yuan JY
    Curr Drug Metab; 2013 Nov; 14(9):989-93. PubMed ID: 24160295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease and cancer: insights for pathogenesis from epidemiology .
    D'Amelio M; Ragonese P; Sconzo G; Aridon P; Savettieri G
    Ann N Y Acad Sci; 2009 Feb; 1155():324-34. PubMed ID: 19250224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease and RLS: the dopaminergic bridge.
    Rye DB
    Sleep Med; 2004 May; 5(3):317-28. PubMed ID: 15165542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death in the substantia nigra: a motor tragedy.
    Esposito E; Di Matteo V; Di Giovanni G
    Expert Rev Neurother; 2007 Jun; 7(6):677-97. PubMed ID: 17563251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis in Parkinson's disease.
    Invernizzi M; Carda S; Viscontini GS; Cisari C
    Parkinsonism Relat Disord; 2009 Jun; 15(5):339-46. PubMed ID: 19346153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual dopaminergic neurons show raised iron levels in Parkinson disease.
    Oakley AE; Collingwood JF; Dobson J; Love G; Perrott HR; Edwardson JA; Elstner M; Morris CM
    Neurology; 2007 May; 68(21):1820-5. PubMed ID: 17515544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive dopamine neuron loss in progressive supranuclear palsy.
    Murphy KE; Karaconji T; Hardman CD; Halliday GM
    Mov Disord; 2008 Mar; 23(4):607-10. PubMed ID: 18163454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
    Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial reactions in Parkinson's disease.
    McGeer PL; McGeer EG
    Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine and adult neurogenesis.
    Borta A; Höglinger GU
    J Neurochem; 2007 Feb; 100(3):587-95. PubMed ID: 17101030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.
    Kas A; Bottlaender M; Gallezot JD; Vidailhet M; Villafane G; Grégoire MC; Coulon C; Valette H; Dollé F; Ribeiro MJ; Hantraye P; Remy P
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1601-8. PubMed ID: 19491921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D and Parkinson's disease.
    Vinh Quôc Luong K; Thi Hoàng Nguyên L
    J Neurosci Res; 2012 Dec; 90(12):2227-36. PubMed ID: 22930493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
    Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
    Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.